Sang‐Ging Ong
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- Pluripotent Stem Cells Research 9
- CRISPR and Genetic Engineering 7
- Mitochondrial Function and Pathology 6
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 4
- Epidemiology 11
- Adipokines, Inflammation, and Metabolic Diseases 6
- Co-authors
- Joseph C. Wu (21 shared papers)Derek J. Hausenloy (9 shared papers)Won Hee Lee (18 shared papers)Kazuki Kodo (9 shared papers)Sang‐Bing Ong (10 shared papers)Antje Ebert (4 shared papers)Melinda L. Telli (2 shared papers)Ronald Witteles (2 shared papers)
- Journals
- Stem Cell Reports (4 papers)Nature Communications (3 papers)Circulation (3 papers)Developmental Cell (2 papers)Frontiers in Cell and Developmental Biology (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Sang‐Ging Ong
56 papers receiving 2.9k citations
Sang‐Ging Ong's Hit Papers
Peers
Comparison fields: 5 of 121
- Cardiology and Cardiovascular Medicine 691
- Cancer Research 390
- Molecular Biology 1.7k
- Aging 39
- Physiology 307
Countries citing papers authored by Sang‐Ging Ong
This map shows the geographic impact of Sang‐Ging Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Ging Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Ging Ong more than expected).
Fields of papers citing papers by Sang‐Ging Ong
This network shows the impact of papers produced by Sang‐Ging Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Ging Ong. The network helps show where Sang‐Ging Ong may publish in the future.
Co-authors
The 25 scholars most cited alongside Sang‐Ging Ong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity Hit paper breakdown → | 2016 | 544 |
| 2 | 2014 | 183 | |
| 3 | 2019 | 154 | |
| 4 | 2014 | 137 | |
| 5 | 2016 | 130 | |
| 6 | 2020 | 109 | |
| 7 | 2019 | 108 | |
| 8 | 2012 | 96 | |
| 9 | 2010 | 92 | |
| 10 | 2014 | 91 | |
| 11 | 2018 | 88 | |
| 12 | 2017 | 87 | |
| 13 | 2015 | 75 | |
| 14 | 2013 | 72 | |
| 15 | 2017 | 62 | |
| 16 | 2016 | 61 | |
| 17 | 2015 | 55 | |
| 18 | 2015 | 53 | |
| 19 | 2015 | 50 | |
| 20 | 2017 | 44 |
About Sang‐Ging Ong
Sang‐Ging Ong is a scholar working on Molecular Biology, Epidemiology, Cardiology and Cardiovascular Medicine, Physiology and Cancer Research, having authored 57 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (9 papers), Adipose Tissue and Metabolism (7 papers), CRISPR and Genetic Engineering (7 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Mitochondrial Function and Pathology (6 papers), MicroRNA in disease regulation (5 papers), RNA Interference and Gene Delivery (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (691 citations), Cancer Research (390 citations), Molecular Biology (1.7k citations), Aging (39 citations) and Physiology (307 citations). Sang‐Ging Ong has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Joseph C. Wu, Derek J. Hausenloy, Won Hee Lee, Kazuki Kodo, Sang‐Bing Ong, Antje Ebert, Melinda L. Telli, Ronald Witteles, Daniel Bernstein and Arun Sharma. Their work appears in journals such as Stem Cell Reports, Nature Communications, Circulation, Developmental Cell and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.